Diagnostics News and Research

RSS

Advanced Cell Diagnostics names Aquila-Histoplex as the first accredited RNAscope® Certified Service Provider in Europe

Aquila-Histoplex, a contract research organisation specialised in histological and multiplex staining technologies, was today announced as the first accredited RNAscope® Certified Service Provider in Europe by Advanced Cell Diagnostics, Inc. (ACD), a technology and market leader in the field of molecular pathology and developer of cell and tissue-based analysis tools.

From Advanced Cell Diagnostics 4 Nov 2014

Gates Foundation awards US$156 million to support PATH Malaria Vaccine Initiative

In support of a bold quest to rid the world entirely of malaria, the Bill & Melinda Gates Foundation today announced an award of US$156 million to PATH to support the PATH Malaria Vaccine Initiative (MVI) in building new vaccines that will interrupt the cycle of malaria parasite transmission and help realize the "accelerating to zero" agenda. Such vaccines would ensure that parasite reintroduction is prevented by providing what could be called an "immunological bed net."

3 Nov 2014

New, easy-to-use test to accelerate progress toward eliminating onchocerciasis in Africa

A new test will accelerate global progress toward eliminating onchocerciasis, a leading cause of preventable blindness in Africa. PATH, an international nonprofit health organization, today announced the availability of the SD BIOLINE Onchocerciasis IgG4 rapid test, manufactured and distributed by Standard Diagnostics, Inc.

3 Nov 2014

Broad Institute, UC Berkeley and UCSC receive NCI Cancer Genomics Cloud Pilot contract

A team from the Broad Institute, the University of California, Berkeley, and the University of California, Santa Cruz, was awarded one of three National Cancer Institute Cancer Genomics Cloud Pilot contracts with the goal of building a system that will enable large-scale analysis of The Cancer Genome Atlas and other datasets by co-locating the data and the required computing resources in one cloud environment.

31 Oct 2014

DNA Diagnostics Forensics recognized at OIP's tenth Anniversary Gala

DNA Diagnostics Forensics, a Division of DNA Diagnostics Center, the world's largest paternity testing company, was honored at Ohio Innocence Project's tenth Anniversary Gala, celebrating freedom for those exonerated, and the organizations that have contributed to the effort.

31 Oct 2014

Special issue of Technology and Innovation includes articles from Patents for Humanity winners

The current special issue of Technology and Innovation, is devoted to patents that benefit people around the world who live with limited resources, in challenging environments, and are in need of better access to basic needs and improved standards of living, health and infrastructure.

31 Oct 2014

Stem cell technologies market expected to show annual increase of 16.2% over 2010-2020

Though therapies are in their nascent phase, sales of stem cell technologies are expected to show an annual increase of 16.2% over the 2010-2020 period, reaching an expected market value of nearly $1 billion, according to Kalorama Information's report, Stem Cell Therapeutics Markets.

31 Oct 2014

Initiative may allow 'instantaneous diagnosis of potentially fatal rhythm disorders' in endurance athletes

The condition of an athlete's heart has for the first time been accurately monitored throughout the duration of a marathon race. The real-time monitoring was achieved by continuous electrocardiogram (ECG) surveillance and data transfer over the public mobile phone network to a telemedicine centre along the marathon route.

31 Oct 2014

Retail health clinics grow steadily in the U.S. due to drug store chains

The number of retail health clinics in the United States is growing steadily, thanks to drug store chains, according to Kalorama Information. In recent years, as a result of the economic downturn, retail clinic growth had been at a standstill, but 2013-14 was a year of opportunities, as the number of retail clinics reached nearly 1,600 according to the healthcare market researcher's report, Retail Clinics Market Overview and 2014 Consumer Survey Results.

30 Oct 2014

EndoChoice study supports Fuse Full Spectrum Endoscopy System

EndoChoice announced the release of study data supporting the efficacy of the Fuse Full Spectrum Endoscopy System. These studies were presented simultaneously by leading gastroenterologists at the American College of Gastroenterology Annual Scientific Session in Philadelphia, PA, and the United European Gastroenterology Week in Vienna, Austria.

30 Oct 2014

BloodCenter of Wisconsin announces availability of cancer mutation HemeOnc Panel

BloodCenter of Wisconsin's Diagnostic Laboratories today announced the availability of a comprehensive cancer mutation HemeOnc Panel using next generation sequencing (NGS) technology. The NGS panel developed by BloodCenter of Wisconsin is designed to detect variants in 30 genes that are either prognostic or diagnostic for 10 different myeloid hematologic malignancies.

30 Oct 2014

UCLA research could lead to simple saliva test for early diagnosis of deadly diseases

UCLA research could lead to a simple saliva test capable of diagnosing — at an early stage — diabetes and cancer, and perhaps neurological disorders and autoimmune diseases.

30 Oct 2014

OCD's ORTHO VISION Analyzer gets CE Mark approval for improved safety of blood transfusions

Ortho-Clinical Diagnostics, Inc. today announced that it obtained CE Mark (Conformité Européenne) for the ORTHO VISION Analyzer, a highly interactive, fully automated analyzer for transfusion medicine laboratories.

From Ortho-Clinical Diagnostics, Inc. 29 Oct 2014

GE Healthcare launches startup campus Health Innovation Village to help entrepreneurs speed up health tech solutions

Today GE Healthcare officially opens Health Innovation Village, its first health tech startup campus, at its Finnish headquarters with the Minister of Economic Affairs in Finland, Jan Vapaavuori and the Mayor of Helsinki, Jussi Pajunen.

29 Oct 2014

ETEC vaccine candidate provides significant protection against bacterial diarrhea

New results from a safety and immunogenicity study, which included a challenge phase to test efficacy, indicate that a live attenuated enterotoxigenic Escherichia coli (ETEC) vaccine candidate, given in combination with a novel adjuvant, provided significant protection against disease.

28 Oct 2014

Diagnostics News and Research

Advanced Cell Diagnostics names Aquila-Histoplex as the first accredited RNAscope® Certified Service Provider in Europe

Gates Foundation awards US$156 million to support PATH Malaria Vaccine Initiative

New, easy-to-use test to accelerate progress toward eliminating onchocerciasis in Africa

Broad Institute, UC Berkeley and UCSC receive NCI Cancer Genomics Cloud Pilot contract

DNA Diagnostics Forensics recognized at OIP's tenth Anniversary Gala

Special issue of Technology and Innovation includes articles from Patents for Humanity winners

Stem cell technologies market expected to show annual increase of 16.2% over 2010-2020

Initiative may allow 'instantaneous diagnosis of potentially fatal rhythm disorders' in endurance athletes

Retail health clinics grow steadily in the U.S. due to drug store chains

EndoChoice study supports Fuse Full Spectrum Endoscopy System

BloodCenter of Wisconsin announces availability of cancer mutation HemeOnc Panel

UCLA research could lead to simple saliva test for early diagnosis of deadly diseases

OCD's ORTHO VISION Analyzer gets CE Mark approval for improved safety of blood transfusions

GE Healthcare launches startup campus Health Innovation Village to help entrepreneurs speed up health tech solutions

ETEC vaccine candidate provides significant protection against bacterial diarrhea

Leica Biosystems signs definitive agreement to purchase Devicor Medical Products

Encouraging Life science Investment in Northern England

Ludwig researchers discover key mechanism that control plasticity of epithelial cells

Research could pave way for more effective drugs to treat inflammation

HRQoL goals may improve outcome in PAH

Industry Focus eBook - Biotechnology (4th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News